UK Biotech Day 2026

Integrated Programs enabled by Translational Pharmaceutics at Quotient Sciences

UK Biotech Day 2026

London, United Kingdom | 27 May 2026 - 28 May 2026
Overview

Connect with Quotient Sciences’ experts who will be attending the UK Biotech Day 2026 event taking place in London on May 27-28, 2026.  

Meet our Business Development team to learn more about our expanded capabilities and how we can help you with your next project.  

You can schedule a partnering meeting with our experts by using the button below.  

Request a meeting with us:
Location
Radisson Hotel And Conference Centre London Heathrow
Building A, Bath Rd, Heathrow Blvd, Sipson, West Drayton UB7 0DU
London, United Kingdom

Global Clinical Trials Connect 2026

Integrated Programs enabled by Translational Pharmaceutics at Quotient Sciences

Global Clinical Trials Connect 2026

London, United Kingdom | 27 May 2026 - 28 May 2026
Overview

Connect with Quotient Sciences’ experts who will be attending the Global Clinical Trials Event 2026 event taking place in London on May 27-28, 2026. 

Meet our Business Development team to learn more about our expanded capabilities and how we can help you with your next project.  

You can schedule a partnering meeting with our experts by using the button below.  

Request a meeting with us:
Location
Copthorne Tara Hotel London Kensington
Scarsdale Pl, W8 5SY
London, United Kingdom

CDMO Live Europe 2026

Integrated Programs enabled by Translational Pharmaceutics at Quotient Sciences

CDMO Live Europe 2026

Rotterdam, Netherlands | 19 May 2026 - 21 May 2026
Overview

Connect with Quotient Sciences’ experts attending CDMO Live Europe in Rotterdam on May 19-21, 2026. 

Meet our Business Development team to learn more about our expanded small molecule CDMO capabilities and how we can help you with your next project. 

You can schedule a partnering meeting with our experts by using the button below.  

Request a meeting with us:
Location
Rotterdam World Trade Center
 Beursplein 37, Meent 110, 3011 AA
Rotterdam, Netherlands

OCT Europe 2026

Integrated Programs enabled by Translational Pharmaceutics at Quotient Sciences

OCT Europe 2026

Barcelona, Spain | 6 May 2026 - 7 May 2026
Overview

Connect with Quotient Sciences’ experts who will be attending the 16th Annual Outsourcing in Clinical Trials Europe event taking place in Barcelona, Spain on May 11-12, 2026. 

Meet our Business Development team to learn more about our expanded capabilities and how we can help you with your next project.  

You can schedule a partnering meeting with our experts by using the button below.  

Request a meeting with us:
Location
Hyatt Regency Barcelona Tower
Avinguda de la Granvia de l’Hospitalet, 144, 08907
Barcelona, Spain

DDF Berlin 2026

Integrated Programs enabled by Translational Pharmaceutics at Quotient Sciences

DDF Berlin 2026

Belin, Germany | 18 May 2026 - 20 May 2026
Overview

Connect with Quotient Sciences’ experts who will be attending the DDF Berlin 2026 event taking place in Berlin on May 18-20, 2026. 

Now in its 17th year, the Global Drug Delivery and Formulation Summit is established as the premier pharmaceutical events for drug delivery, formulation and device professionals.

Meet our Business Development team to learn more about our expanded capabilities and how we can help you with your next project.  

You can schedule a partnering meeting with our experts by using the button below.  

Request a meeting with us:
Location
Maritim proArte Hotel
Friedrichstraße 151, Dorotheenstraße 65,10117 
Belin, Germany

Swiss Biotech Day 2026

Integrated Programs enabled by Translational Pharmaceutics at Quotient Sciences

Swiss Biotech Day 2026

Basel, Switzerland | 4 May 2026 - 5 May 2026
Overview

Connect with Quotient Sciences’ experts who will be attending the Swiss Biotech Day 2026 event taking place in Basel on May 4-5, 2026. 

Registration for this event is closed.

You can schedule a meeting with our experts by using the button below. 

Location
Congress Center
Messepl. 21, 4058
Basel, Switzerland

CPHI Japan 2026

Integrated Programs enabled by Translational Pharmaceutics at Quotient Sciences

CPHI Japan 2026

Koto City, Tokyo, Japan | 21 April 2026 - 23 April 2026
Overview

Connect with Quotient Sciences’ experts who will be at the CPHI Japan event taking place in Tokyo on April 21-23, 2026.   

Stop by our booth or schedule a meeting with our experts by using the button below.

Request a meeting with us:
Location
Tokyo Big Sight East Halls 1,2,3
3 Chome-11-1 Ariake, 135-0063
Koto City, Tokyo, Japan

Co-administering clofazimine with infant formula enhances its oral bioavailability in rats and pigs

Articles & Publications , Pediatrics , Pharmacokinetics

Co-administering clofazimine with infant formula enhances its oral bioavailability in rats and pigs

13 February 2026
  • Home
  • Resources
  • Co-administering clofazimine with infant formula enhances its oral bioavailability in rats and pigs
Overview

This study investigates the feasibility of using commercially available infant formula as an enabling formulation to enhance the solubilization and oral bioavailability of clofazimine, a poorly soluble lipophilic drug.

The solubilization of crystalline clofazimine in digesting infant formula was assessed in vitro using synchrotron small-angle X-ray scattering. An in vivo pharmacokinetic study was then conducted to determine the oral bioavailability of a suspension of clofazimine in infant formula compared to a lipid-free aqueous suspension in both a rat and piglet animal model.

Read the findings of the poster, with contributions from our experts including Vanessa Zann, Vice President of Scientific Consulting.

Download
Date
13 February 2026

Des Glass - Executive Vice President & Chief Financial Officer

Dess Glass

Des Glass

Executive Vice President & Chief Financial Officer

Executive Leader
About

Des Glass is Executive Vice President and Chief Financial Officer, bringing over two decades of senior financial leadership across multinational, publicly listed, and high‑growth organizations. He joined Quotient Sciences in April 2022, applying deep expertise in strategic financial management, capital optimisation, and operational alignment, along with significant experience scaling international companies and driving financial performance.

Before joining Quotient Sciences, Des served as Group CFO at RWS Holdings plc, the world’s leading provider of technology localisation and language services, where he helped accelerate global expansion through strategic acquisitions and operational transformation. Previously, he spent nine years as CFO of GAN plc, where he helped guide the business from a fast‑moving technology start‑up to a successful AIM flotation and expanded its operations across the US and Europe. His earlier career included senior finance roles at Rodale, Primedia, and ABC in New York, strengthening his leadership experience across media and technology‑driven businesses across international markets.

Des began his career at Deloitte, is a Fellow of the Institute of Chartered Accountants in Ireland, and holds an MBA from Imperial College London.

Phase I/Clinical Pharmacology Info Sheet

Info Sheets , Clinical Pharmacology , Regulatory Affairs

Phase I/Clinical Pharmacology Info Sheet

Overview

Providing crucial data in early clinical development is key to ensuring program success and product approval.

At Quotient Sciences, our comprehensive, end-to-end services encompass expert clinical study design, thorough data analysis, and detailed reporting. Bringing over three decades experience in clinical pharmacology to every customer program, our team has conducted over 2,000 Phase I studies in our US and UK clinical units, including more than 200 DDI studies and 400 human ADME studies.

Learn more about our capabilities in Phase I clinical pharmacology and regulatory & labeling studies today.

Download
Subscribe to